Hirata, S., Marotta, A., Gui, Y., Hanami, K., & Tanaka, Y. (2015). Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab. Arthritis Res Ther.

Hirata, Shintaro, Anthony Marotta, Yuan Gui, Kentaro Hanami, e Yoshiya Tanaka. "Serum 14-3-3η Level Is Associated With Severity and Clinical Outcomes of Rheumatoid Arthritis, and Its Pretreatment Level Is Predictive of DAS28 Remission With Tocilizumab." Arthritis Res Ther 2015.

Hirata, Shintaro, et al. "Serum 14-3-3η Level Is Associated With Severity and Clinical Outcomes of Rheumatoid Arthritis, and Its Pretreatment Level Is Predictive of DAS28 Remission With Tocilizumab." Arthritis Res Ther 2015.